Molly L Tanenbaum
Overview
Explore the profile of Molly L Tanenbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
847
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A Qualitative Study of Older Adult Perspectives on Continuous Glucose Monitoring for Type 2 Diabetes
Tanenbaum M, Peterson I, Uratsu C, Chen M, Gilliam L, Karter A, et al.
J Gen Intern Med
. 2025 Mar;
PMID: 40038224
Background: Continuous glucose monitoring (CGM) may improve self-management and reduce hypoglycemia risk among individuals with diabetes. However, little is known about how older adults with insulin-treated type 2 diabetes (T2D)...
2.
Steinberg D, Mulinda C, Castano K, DiCola K, Tanenbaum M, Onderwyzer Gold A, et al.
J Pediatr Psychol
. 2024 Nov;
50(2):187-196.
PMID: 39607985
Objective: Sickle cell disease (SCD) is associated with significant morbidity and mortality. Hematopoietic stem cell transplantation (HCT) can improve health-related quality of life (HRQOL) but may be physically and emotionally...
3.
Tanenbaum M, Commissariat P, Wilmot E, Lange K
J Diabetes Sci Technol
. 2024 Aug;
19(1):47-53.
PMID: 39212371
Advances in diabetes technologies have enabled automated insulin delivery (AID) systems, which have demonstrated benefits to glycemia, psychosocial outcomes, and quality of life for people with type 1 diabetes (T1D)....
4.
Mayberry L, Nelson L, Bergner E, Raymond J, Tanenbaum M, Jaser S, et al.
J Diabetes Sci Technol
. 2024 Aug;
:19322968241268560.
PMID: 39143688
Continuous glucose monitors (CGMs) improve glycemic outcomes and quality of life for many people with diabetes. Research and clinical practice efforts have focused on CGM initiation and uptake. There is...
5.
Tanenbaum M, Pang E, Tam R, Bishop F, Prahalad P, Zaharieva D, et al.
Diabet Med
. 2024 Aug;
41(12):e15423.
PMID: 39118381
Aims: Continuous glucose monitoring (CGM) systems are standard of care for youth with type 1 diabetes with the goal of spending >70% time in range (TIR; 70-180 mg/dL, 3.9-10 mmol/L)....
6.
Tanenbaum M, Addala A, Hanes S, Ritter V, Bishop F, Cortes A, et al.
J Diabetes Complications
. 2023 Dec;
38(1):108651.
PMID: 38043358
Aims: This pilot study delivered a comprehensive exercise education intervention to youth with new-onset type 1 diabetes (T1D) and their parents to increase knowledge and confidence with physical activity (PA)...
7.
Tanenbaum M, Commissariat P
Endocr Connect
. 2023 Jul;
12(10).
PMID: 37522857
Diabetes technology continues to advance, with more individuals with type 1 diabetes (T1D) adopting insulin pumps, continuous glucose monitoring (CGM), and automated insulin delivery (AID) systems that integrate real-time glucose...
8.
Addala A, Wong J, Medina Penaranda R, Hanes S, Abujaradeh H, Adams R, et al.
J Diabetes Complications
. 2023 Jun;
37(7):108514.
PMID: 37263033
Aim: Youth from lower socioeconomic status (SES) have suboptimal type 1 diabetes (T1D) outcomes. Patient reported outcomes (PROs) measure psychosocial states and are associated with T1D outcomes, however are understudied...
9.
Wong J, Addala A, Hanes S, Krugman S, Naranjo D, Nelmes S, et al.
J Diabetes
. 2023 May;
15(7):597-606.
PMID: 37139842
Background: DiabetesWise is an unbranded, data-driven online resource that tailors device recommendations based on preferences and priorities of people with insulin-requiring diabetes. The objective of this study is to examine...
10.
Tanenbaum M, Zaharieva D, Addala A, Prahalad P, Hooper J, Leverenz B, et al.
Diabet Med
. 2022 Jul;
39(11):e14923.
PMID: 35899591
Aim: Initiating continuous glucose monitoring (CGM) shortly after Type 1 diabetes diagnosis has glycaemic and quality of life benefits for youth with Type 1 diabetes and their families. The SARS-CoV-2...